Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States

Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States

Accurate estimates of infection prevalence and seroprevalence are essential for evaluating and informing public health responses and vaccination coverage needed to address the ongoing spread of COVID-19 in each United States (U.S.) state. However, reliable, timely data based on representative popula...

Full description

Bibliographic Details
Main Authors: Chiu, W.A (Author), Ndeffo-Mbah, M.L (Author)
Format: Article
Language:English
Published: Public Library of Science 2021
Subjects:
Antibodies, Viral
Article
Bayesian network
biology
blood
Computational Biology
controlled study
coronavirus disease 2019
cost effectiveness analysis
COVID-19
COVID-19 Testing
diagnosis
disease simulation
disease transmission
epidemiology
human
Humans
immunology
mass screening
Mass Screening
Models, Statistical
pandemic
positivity rate
prevalence
Prevalence
public health
regression analysis
sensitivity analysis
seroconversion
Seroepidemiologic Studies
seroepidemiology
seroprevalence
statistical model
United States
vaccination
vaccination coverage
virus antibody
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items